Circulation-Cardiovascular Interventions

Article	Citations
Novel Antithrombotic Strategies After Surgical Bioprosthetic Valve Replacement	126
Age-Related Outcomes After Revascularization for Chronic Limb-Threatening Ischemia: An Analysis of BEST-CLI	116
Adjunctive Imaging and Physiology During PCI Among Black and White Medicare Beneficiaries: Disparities in Utilization Patterns and Outcomes	81
The Beaten Path: Use of the Radial Artery as a Bypass Graft After Instrumentation	73
ACURATE neo2 Versus SAPIEN 3 Ultra Transcatheter Heart Valve in Severe Aortic Valve Calcification: A Propensity-Matched Analysis	72
Impacts of Hospital Volume and Patient-Hospital Distances on Outcomes of Older Adults Receiving Percutaneous Microaxial Ventricular Assist Devices for Cardiogenic Shock	63
Prospective Multicenter IDE Study of the Next-Generation Precision Aspiration Thrombectomy System for Intermediate-Risk Pulmonary Embolism: The SYMPHONY-PE Trial	63
Transcatheter Mitral Valve Replacement With Atrial Fixation for Treatment of Atrial Functional Mitral Regurgitation	60
Impact of Cerebral Embolic Protection Devices on Disabling Stroke After TAVR: Updated Results From the STS/ACC TVT Registry	59
Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial	55
Contemporary State-of-the-Art PCI of Left Main Coronary Artery Disease	54
Efficacy of the Glucagon-Like Peptide-1 Agonist Exenatide in Patients Undergoing CABG or Aortic Valve Replacement: A Randomized Double-Blind Clinical Trial	53
Percutaneous Balloon–Expandable Stent Implantation to Treat Transverse Aortic Arch Obstruction: Medium- to Long-Term Outcomes of a Retrospective Multicenter Study	49
Perfect Wedding Between Patient With STEMI and Angiography-Derived Indexes of Coronary Physiology	46
Supplementing Randomized Trial Data to Answer a Real-World Question: Discharge to Home Status as a Heuristic for Stroke Severity After TAVR	45
Letter by Güner et al Regarding Article, “Clinical Outcomes of Percutaneous Transcatheter Release of Stuck Mechanical Mitral Valve With Cerebral Embolic Protection”	43
Temporal Trends in In-Hospital Outcomes Following Unprotected Left-Main Percutaneous Coronary Intervention: An Analysis of 14 522 Cases From British Cardiovascular Intervention Society Database 2009 t	42
Optimal Hemostatic Band Duration After Transradial Angiography or Intervention: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials	40
Prognostic Role of Residual Thrombus Burden Following Thrombectomy: Insights From the TOTAL Trial	40
Visual Estimates of Coronary Slow Flow Are Not Associated With Invasive Wire-Based Diagnoses of Coronary Microvascular Dysfunction	39
Racial Disparities in Invasive Management for Patients With Acute Myocardial Infarction With Chronic Kidney Disease	38
Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions	37
Response by Yamamoto et al to Letter Regarding Article, “Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention”	35
Effect of Evolocumab in Patients With Prior Percutaneous Coronary Intervention	35
Angina After Percutaneous Coronary Intervention?	34

Is Routine Postdilation During Angiography-Guided Stent Implantation as Good as Intravascular Ultrasound Guidance?: An Analysis Using Data From IVUS-XPL and ULTIMATE	33
Transcarotid Versus Surgical Aortic Valve Replacement for the Treatment of Severe Aortic Stenosis	33
Impact of Interdisciplinary System-Wide Limb Salvage Advisory Council on Lower Extremity Major Amputation	33
Giant Aberrant Vascular Structure Extending From the Left Ventricular Apex to the Umbilicus in a Newborn With Cantrell Pentalogy: Management and Transcatheter Closure	33
Intravascular Imaging for Optimal Left Main Percutaneous Coronary Intervention: A Requirement Rather Than an Option	33
Tricuspid Clip at 2 Years: Clocking the Development of a Rapidly Expanding Space	32
Letter by Garmendia and Garcia-Garcia Regarding Article, “Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention”	32
Transcatheter Nonductal Reverse Potts Shunt Creation in Pulmonary Arterial Hypertension	32
Posting Another Win for Intravascular Imaging: Moving Away From Angiography-Only Percutaneous Coronary Intervention Toward a More Comprehensive Approach	31
Simple Maneuver to Improve TriClip Eligibility in Patients With Cardiac Implantable Electronic Device Leads	30
Workflow for Percutaneous Coronary Intervention With Optical Coherence Tomography-Guidance: MAXing the MLD?	30
A Tale of Two Polymers: Bioprosthetic Valve Remodeling Versus Bioprosthetic Valve Fracture of Mosaic Surgical Valves to Facilitate VIV TAVR	30
Transapical Beating-Heart Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy: Lessons Learned After the Learning Curve Period	29
Microvascular and Macrovascular Disease: The S’mores of Peripheral Artery Disease	28
Will a Conservative Case Selection Strategy Improve Hospital-Level TAVR Performance Metrics?	28
Microvascular Function and Ambulatory Capacity in Peripheral Artery Disease	28
Biodegradable Polymer Versus Polymer-Free Ultrathin Sirolimus-Eluting Stents: Analysis of the Stent Arm Registry From the HOST-IDEA Randomized Trial	28
Contemporary Anatomic Criteria and Clinical Outcomes With Transcatheter Mitral Repair	27
Outcomes in High-Risk Pulmonary Embolism Patients Undergoing FlowTriever Mechanical Thrombectomy or Other Contemporary Therapies: Results From the FLAME Study	27
Composite Pulmonary Embolism Shock Score and Risk of Adverse Outcomes in Patients With Pulmonary Embolism	27
Why Age Matters: Revascularization Strategy and Outcomes in Young and Elderly With CLTI	26
Comparative Outcomes of Transcatheter Edge-to-Edge Repair and Tricuspid Valve Surgery for Isolated Tricuspid Valve Regurgitation	26
Does CRT Reduce Health Care–Related Costs in Patients With ANOCA?	25
Mechanisms Matter: Combining Invasive Metrics to Better Define Microvascular Dysfunction	25
One-Year Outcomes of Transseptal Mitral Valve-in-Valve in Intermediate Surgical Risk Patients	25
Fetal Atrial Septal Intervention for HLHS With Restrictive Septum: Promising Progress, Persistent Questions	25
Comparison of Intracoronary Epinephrine and Adenosine for No-Reflow in Normotensive Patients With Acute Coronary Syndrome (COAR Trial)	25
Early Versus Delayed Invasive Management of Female Patients With Non–ST-Elevation Acute Coronary Syndrome: An Individual Patient Data Meta-Analysis	24
Outcomes of Transcatheter Tricuspid Edge-to-Edge Repair in Patients With Right Ventricular Dysfunction	24
Deferred Versus Performed Revascularization for Left Main Coronary Disease With Hemodynamic Significance	24
Neo-Commissural Alignment Technique for Transcatheter Aortic Valve Replacement Using the ACURATE Neo Valve	24
Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis Patients	24
Reperfusion Delays and Outcomes Among Patients With ST-Segment–Elevation Myocardial Infarction With and Without Cardiogenic Shock	24
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk	23
Upping the Transcatheter Edge-to-Edge Repair Game: Patient Selection Based on Newly Described Echocardiographic Measurements	23
Clinical Value of Single-Projection Angiography–Derived FFR in Noninfarct-Related Artery	23
Editors and Editorial Board	23
Large Animal Translational Validation of 3 Mitral Valve Repair Operations for Mitral Regurgitation Using a Mitral Valve Prolapse Model: A Comprehensive In Vivo Biomechanical Engineering Analysis	23
Graft Patency and Clinical Outcomes in Patients With Radial Artery Grafts Previously Instrumented for Cardiac Catheterization	23
Hybrid Versus Percutaneous Left Atrial Decompression in Infants With Hypoplastic Left Heart Variants and an Intact or Highly Restrictive Atrial Septum: A Multicenter PICES Study	20
Long-Term Outcomes Following Sirolimus-Coated Balloon or Drug-Eluting Stents for Treatment of In-Stent Restenosis	20
Enhancing Coronary Revascularization Decisions: The Promising Role of Large Language Models as a Decision-Support Tool for Multidisciplinary Heart Team	19
Comparison of Unguided De-Escalation Versus Guided Selection of Dual Antiplatelet Therapy After Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis	19
Enhancing Guidewire Efficacy for Transradial Access: The EAGER Randomized Controlled Trial	19
Effects of Guiding Catheter Disengagement on Resting Indexes for the Assessment of Coronary Artery Stenoses	19
Extended Rhythm Monitoring to Assess for Ventricular Arrhythmias After Transcatheter Pulmonary Valve Replacement With the Harmony Valve	19
Impact of Left Atrial Pressure on Outcomes After Mitral Transcatheter Edge-to-Edge Repair	19
Technical Advances and Outcomes of Fetal Atrial Septal Intervention for Restrictive or Intact Atrial Septum	18
Angiography-Derived Index of Microcirculatory Resistance to Define the Risk of Early Discharge in STEMI	18
Invasive Coronary Function Testing in Patients With Prior PCI Who Have Persistent ANOCA	18

Response to Letter by Piriou et al Regarding Article, “Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation”	18
Association Between Polyvascular Disease and Transcatheter Aortic Valve Replacement Outcomes: Insights From the STS/ACC TVT Registry	18
What Predicts the Success of Alcohol Septal Ablation?: The Myocardium Counts, After All	18
Still a Long Way to the Precision Medicine of Antiplatelet Strategy After Percutaneous Coronary Intervention	18
Comparison of Transcatheter Edge-to-Edge Mitral Valve Repair for Primary Mitral Regurgitation Outcomes to Hospital Volumes of Surgical Mitral Valve Repair	18
Diagnostic Validity of Acetylcholine Provocation Protocols in the Evaluation of Coronary Artery Spasm in Patients With ANOCA	18
Associations of Sarcopenia and Body Composition Measures With Mortality After Transcatheter Aortic Valve Replacement	17
Stent-Edge Hinge Movement in a Calcified Lesion Is Associated With Increased Prevalence of a Calcified Nodule at Follow-Up	17
Efficacy and User Experience of a Novel X-Ray Shield on Operator Radiation Exposure During Cardiac Catheterization: A Randomized Controlled Trial	17
Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry	17
More Is Not Always Better: Reassessing Acetylcholine Provocation in the Diagnosis of Coronary Vasospasm	17
Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE Trial	17
Coronary Angiography-Derived Index of Microcirculatory Resistance Predicts Outcome in Patients With ST-Segment–Elevation Myocardial Infarction	17
Letter by Skalidis et al Regarding Article, “Comparing the Efficacy of Sirolimus and Paclitaxel-Eluting Balloon Catheters in the Treatment of Coronary In-Stent Restenosis: A Prospective Randomized Stu	17
Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial	17
Transcatheter Mitral Valve-in-Valve Replacement as a First-Line Treatment for Bioprosthetic Valve Failure	16
Percutaneous Coronary Intervention Following Diagnostic Angiography by Noninterventional Versus Interventional Cardiologists: Insights From the CathPCI Registry	16
Invasive or CT Angiography: Alternative or Complementary Imaging Tools After CABG?	16
Direct Oral Anticoagulants Versus Antiplatelet Therapy After Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Trials	16
Metrics to Assess Quality Following Percutaneous Coronary Intervention Complications: Is “Failure to Rescue” an Answer?	16
Randomized Study Comparing Angiography Guidance With Physiology Guidance After PCI: The EASY-PREDICT Study	16
Sirolimus-Coated Balloons for In-Stent Restenosis: The Evolution of PCI	15
Natural History of Coronary Atherosclerosis in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: The Role of Quantitative Flow Ratio	15
Risk Prediction in Percutaneous Coronary Intervention: Solving the Last Mile Problem	15
Shorter Time to Transcatheter Aortic Valve Implantation Is Associated With Improved Outcomes in Acute Decompensated Aortic Stenosis	15
Patterns of Restenosis After Left Main Bifurcation Single- or Dual-Stenting: An EBC MAIN Trial Subanalysis	15
Temporal Changes in Procedural Success and Clinical Outcomes of MTEER by Mechanism of MR: Analysis of the STS/TVT Registry	15
Expanding Transcatheter Tricuspid Valve Replacement Applicability—Beyond Device Iterations	14
Pulmonary Artery Systolic Pressure Trajectories After Transcatheter Edge-to-Edge Repair in Atrial and Ventricular Secondary Mitral Regurgitation	14
Hemodynamic Comparison of Resilia and Sapien 3/Ultra Transcatheter Heart Valves in Transcatheter Aortic Valve Replacement	14
Implementation of a Multidimensional Strategy to Reduce Post-PCI Bleeding Risk	14
Coronary Artery Obstruction After Transcatheter Aortic Valve Implantation: Past, Present, and Future	14
Sex Differences in Health Status and Clinical Outcomes After Nonprimary Percutaneous Coronary Intervention	14
Transcatheter Valve Replacement in Adults With Congenital Heart Disease—The Mayo Clinic Experience	14
Patient-Reported Outcome Measures in Symptomatic, Non–Limb-Threatening Peripheral Artery Disease: A State-of-the-Art Review	14
Hemodynamic Super-Responders in Pulmonary Embolism: Optimism and Uncertainty	13
Novel Real-Time Fluoroscopic Assessment Method of THV Expansion Following Balloon-Expandable TAVR	13
Percutaneous Coronary Intervention Operator Profiles and Associations With In-Hospital Mortality	13
Impact of Intensity of Vascular Care Preceding Major Amputation Among Patients With Chronic Limb-Threatening Ischemia	13
Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Evolut PRO/PRO+ Self-Expanding Valves: Insights From the NEOPRO/NEOPRO-2 Registries	13
PCI for Surgically Ineligible Patients: Another Piece of the Jigsaw	13
Dynamic Nature of the Hyperemic Continuum	13
Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves	13
Feasibility of Redo-Transcatheter Aortic Valve Replacement in Sapien Valves Based on In Vivo Computed Tomography Assessment	13
Time Course of Microvascular Stunning in ST-Segment–Elevation Myocardial Infarction	12
Cost-Effectiveness of Percutaneous Coronary Intervention Versus Bypass Surgery for Patients With Left Main Disease: Results From the EXCEL Trial	12
FFR-Negative Nonculprit High-Risk Plaques and Clinical Outcomes in High-Risk Populations: An Individual Patient-Data Pooled Analysis From COMBINE (OCT-FFR) and PECTUS-obs	12
Navigating the Course of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Review of Guided Approaches	12
Virtual FFR From Optical Coherence Tomography: A 1-Stop Shop for PCI Guidance?	12
Single Bolus r-SAK Before Primary PCI for ST-Segment–Elevation Myocardial Infarction	12
TMVR for the Treatment of Mitral Regurgitation: A State-of-the-Art Review	12
Challenges and Evolving Strategies in the Treatment of In-Stent Restenosis With Drug-Coated Balloons	12
Response by Costa et al to Letter Regarding Article, “Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation”	12
Short-Term Postoperative Use of Rivaroxaban to Prevent Radial Artery Occlusion After Transradial Coronary Procedure: The RESTORE Randomized Trial	12
Association Between Artificial Intelligence Detected Features on the ECG and Presence of Microvascular Obstruction	12
Ultra-Low Contrast IVUS-Guided PCI in Patients With Severe Chronic Kidney Disease: An Observational Prospective Study	12
Impact of Pullback Pressure Gradient on Clinical Outcomes after Percutaneous Coronary Interventions	11
CCTA-Guided Invasive Coronary Angiography in Patients With CABG: A Multicenter, Randomized Study	11
Prognostic Impact of Left Atrial Appendage Patency After Device Closure	11
Change in Left Ventricular Ejection Fraction With Coronary Artery Revascularization and Subsequent Risk for Adverse Cardiovascular Outcomes	11
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort	11
Editors and Editorial Board	11
Statewide Initiative to Reduce Patient Radiation Doses During Percutaneous Coronary Intervention	11
Predictive Value of Platelet FcγRIIa in Patients Treated With PCI Compared With Medical Therapy Alone After Myocardial Infarction	11
Clinical Benefit of Intravascular Imaging Compared With Conventional Angiography in Left Main Coronary Artery Intervention	11
Response by Brilakis et al to Letter Regarding Article, “Chronic Total Occlusion Percutaneous Coronary Intervention: Present and Future”	10
Percutaneous Thoracic Duct Externalization and Autotransfusion in Patients With Lymphatic Failure Due to Elevated Central Venous Pressure	10
Intravascular Imaging-Guided Versus Angiography-Guided Complex PCI in Patients With High Bleeding Risk: A Secondary Analysis of the RENOVATE-COMPLEX PCI Trial	10
ELLIS Study: Comparative Analysis of Excimer Laser Coronary Angioplasty and Intravascular Lithotripsy on Drug-Eluting Stent as Assessed by Scanning Electron Microscopy	10
Optimization of Absolute Coronary Blood Flow Measurements to Assess Microvascular Function: In Vivo Validation of Hyperemia and Higher Infusion Speeds	10
Clinical Features and Outcomes Among Patients With Refractory Out-of-Hospital Cardiac Arrest and an Initial Shockable Rhythm	10
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: A Nationwide Prospective Multicenter Registry in Japan (J-BPA)	10
CT Simulation for Redo-TAVR: Can We Predict Future Coronary Access?	10
Correction to: Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention	10
Safety and Efficacy of Percutaneous Left Atrial Appendage Closure Without Preprocedural Imaging	10
Long Term Outcomes After Renal Revascularization for Atherosclerotic Renovascular Disease in the ASTRAL Trial	10
Coronary Sinus Reduction: Can Device-Based Therapy Improve Coronary Microvascular Function?	9
Does the Timing Matter in Invasive Management of Non–ST-Segment–Elevation Acute Coronary Syndrome?	9
Evaluation of Instantaneous Wave-Free Ratio and Fractional Flow Reserve in Severe Aortic Valve Stenosis	9
Correction to: Large Diameter Advanta V12 Covered Stent Trial for Coarctation of the Aorta: COARC Study	9

Response by Maznyczka et al to Letter Regarding Article, “Patterns of Restenosis After Left Main Bifurcation Single- or Dual-Stenting: An EBC MAIN Trial Subanalysis”	9
Sex Differences in Culprit Plaque Characteristics Among Different Age Groups in Patients With Acute Coronary Syndromes	9
Correction to: Transcatheter Aortic Valve Replacement and Impact of Subclinical Leaflet Thrombosis in Low-Risk Patients: LRT Trial 4-Year Outcomes	8
Ultrasound-Guided Transfemoral Access for Coronary Procedures: A Pooled Learning Curve Analysis From the FAUST and UNIVERSAL Trials	8
Atrial Functional Tricuspid Regurgitation: Novel Definition and Impact on Prognosis	8
New Beat: Tracing the Journey of Transcatheter Pulmonary Valve Replacement	8
Rising Use of Percutaneous Ventricular Assist Devices: What Can Be Learned From the Data?	8
Letter by Kawashima et al Regarding Article, “Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Patients With Chronic Total Occlusion and Multivessel Disease”	8
Optical Coherence Tomography Versus Angiography Alone to Guide PCI for Complex Lesions: A Meta-Analysis of Randomized Controlled Trials	8
Impact of Balloon Postdilation on Long-Term Bioprosthesis Durability After TAVR	8
Antithrombotic Management After Left Atrial Appendage Closure: Current Evidence and Future Perspectives	8
Native and Post-Repair Residual Mitral Valve Prolapse Increases Forces Exerted on the Papillary Muscles: A Possible Mechanism for Localized Fibrosis?	8
Clopidogrel Versus Aspirin Beyond 30 Days: Different Drugs, Same Outcomes?	8
Safety and Effectiveness of Intracoronary Imaging-Guided PCI in Contemporary Practice: Insights From BMC2	8
Recurrent Mitral Regurgitation After MitraClip: Defining Success and Predicting Outcomes	8
Incidence and Impact of Contrast-Associated Acute Kidney Injury in Patients With High-Bleeding Risk Undergoing Percutaneous Coronary Intervention	8
Anatomically Directed Lower Extremity Gene Therapy for Ulcer Healing: A Double-Blind, Randomized, Placebo-Controlled Study (LEGenD-1)	7
BioMatrix Versus Orsiro Stents for Coronary Artery Disease: A Multicenter, Randomized, Open-Label Study	7
Relation of Residual Mitral Regurgitation and Gradient Following Mitral Valve Transcatheter Edge-to-Edge Repair	7
Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Patients With Chronic Total Occlusion and Multivessel Disease	7
Optimal Degree of Balloon-Expandable Transcatheter Valve Oversizing in Patients With Borderline Aortic Annulus Measurements: Insights From a Multicenter Real-World Experience	7
Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical Bioprosthetic Valve Replacement: A Randomized Clinical Trial	7
Correction to: Contributors to the Growth of Same Day Discharge After Elective Percutaneous Coronary Intervention	7
More Versus Better: Learning From the Medtronic Valiant Navion Recall	7
Valve-in-Valve TAVR in Patients With Failed Trifecta Bioprosthetic Aortic Valves	7
Device-Related Findings on Computed Tomography After Transcatheter Pulmonary Valve Replacement With the Harmony Valve	7
Impact of Intravascular Ultrasound–Derived Lesion-Specific Virtual Fractional Flow Reserve Predicts 3-Year Outcomes of Untreated Nonculprit Lesions: The PROSPECT Study	7
CTCA Prior to Invasive Coronary Angiography in Patients With Previous Bypass Surgery: Patient-Related Outcomes, Imaging Resource Utilization, and Cardiac Events at 3 Years From the BYPASS-CTCA Trial	7
First-in-Human Endovascular Aortic Root Repair (Endo-Bentall) for Acute Type A Dissection	7
Go With the Flow: Does Clinical Equipoise Remain for Deferral of Angiographically Intermediate Left Main Coronary Artery Disease With Hemodynamic Significance?	7
Long-Term Outcomes in Adult Patients With Pulmonary Hypertension After Percutaneous Closure of Atrial Septal Defects	7
Drug-Coated Balloons With or Without Provisional Bare Metal Stenting in Femoropopliteal Disease: No Metal Left Behind?	7
Utilization and Outcomes Associated With Intravascular Ultrasound During Abdominal and Thoracic Endovascular Aortic Interventions in the United States in the Contemporary Era (2016–2023)	7
Impact of Calcium Eccentricity on the Safety and Effectiveness of Coronary Intravascular Lithotripsy: Pooled Analysis From the Disrupt CAD Studies	7
Prevalence and Impact of Neoatherosclerosis on Clinical Outcomes After Percutaneous Treatment of Second-Generation Drug-Eluting Stent Restenosis	7
Procedural and Clinical Outcomes According to Ultrasound-Guided Access in TAVI: A Propensity-Matched Comparative Subanalysis From the PULSE Registry	6
Health Care Cost and Resource Utilization After Aortic Valve Replacement According to the Extent of Cardiac Damage	6
Coronary Atherosclerosis Phenotypes in Non–Flow-Limiting Nonculprit Lesions of Older Patients With MI Stratified by Focal and Diffuse Disease Patterns	6
Physiologic Assessment of Left Main Disease: Still a Complex Art	6
Comparative Effectiveness of TAVI Platforms and Surgical Aortic Valve Replacement: A Network Meta-Analysis of Randomized Controlled Trials	6
Economics of Minimalist Transcatheter Aortic Valve Replacement: Results From the 3M-TAVR Economic Study	6
Response by Vilalta et al to Letter Regarding Article, “Midterm Outcomes Following Sutureless and Transcatheter Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis”	6
Calculating Relative Lung Perfusion Using Fluoroscopic Sequences and Image Analysis: The Fluoroscopic Flow Calculator	6
Impact of Bifurcation Lesions on Outcomes After FFR-Guided PCI or CABG	6
Response by Ulacia Flores and Bertrand to Letter Regarding Article, “Randomized Study Comparing Angiography Guidance With Physiology Guidance After PCI: The EASY-PREDICT Study”	6
Subclinical Thrombosis on Valve Durability in Low-Risk Transcatheter Aortic Valve Replacement Patients: Mid-Term Data Reassuring, but Longer Follow-Up Needed	6
Percutaneous Left Ventricular Unloading During High-Risk Coronary Intervention: Rationale and Design of the CHIP-BCIS3 Randomized Controlled Trial	6
Evolution of Cardiac Damage Following SAVR in Asymptomatic Severe Aortic Stenosis	6
Hemodynamic Effects of Transcatheter Tricuspid Valve Annuloplasty With Cardioband and Their Associations With Clinical Outcomes	6
Response by Amat-Santos et al to Letter Regarding Article, “Laser Coronary Atherectomy and Polymeric Coronary Wires in Uncrossable Lesions: a Word of Caution”	6
Prioritizing Rapid Reperfusion in ST-Segment–Elevation Myocardial Infarction Complicated by Cardiogenic Shock: Leveraging Regionalized Systems of Care	6
Drug-Coated Balloon Use in Contemporary Coronary Angioplasty: Is the Jury Still Out?	6
Association Between Neurological Status and Outcomes in Cardiac Arrest Patients Undergoing PCI in Contemporary Practice: Insights From BMC2	6
Five-Year Outcomes After Fractional Flow Reserve–Based Deferral of Revascularization in Chronic Coronary Syndrome: Final Results From the J-CONFIRM Registry	6
Catheter-Induced Postextrasystolic Potentiation in the Assessment of Severity of Low-Gradient Aortic Valve Stenosis	6
Ischemia in Anomalous Aortic Origin of a Right Coronary Artery: Large Pediatric Cohort Medium-Term Outcomes	6
Hemodynamic Super-Response to Mechanical Thrombectomy in Patients With Intermediate-Risk Pulmonary Embolism	6
Left Main Coronary Artery Intervention: Respect the Circumflex	6
Prediction of Heart Failure Hospitalization or Death After TAVR	6
Relative Benefit of Dual Versus Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI: Insights From the AUGUSTUS Trial	6
Transcatheter Aortic Valve Replacement With the Evolut FX Self-Expanding Versus SAPIEN 3 Ultra Resilia Balloon-Expandable Valves	6
Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial	6
Contemporary TAVR for Patients With Bicuspid Aortic Valve: Importance of Specific Bicuspid Phenotypes, Raphe, Calcification, and a Lifetime Management Intention	5
Postimplantation Size of WATCHMAN FLX Pro: A New Left Atrial Appendage Closure System	5
Expansion of Transcatheter Aortic Valve Implantation and Mortality due to Aortic Stenosis Between 2010 and 2019	5
Redo-TAVR Feasibility After SAPIEN 3 Stratified by Implant Depth and Commissural Alignment: A CT Simulation Study	5
Role of Quantitative Flow Ratio in Predicting Future Cardiac Allograft Vasculopathy in Heart Transplant Recipients	5
Transcatheter Patent Ductus Arteriosus Closure in Premature Infants: A Multicenter Retrospective Study Comparing Available Devices	5
Letter by Henry and Widmer Regarding Article, “Visual Estimates of Coronary Slow Flow Are Not Associated With Invasive Wire-Based Diagnoses of Coronary Microvascular Dysfunction”	5
Hemodynamic Success Is an Independent Predictor of Mid-Term Survival After Transcatheter Edge-to-Edge Mitral Valve Repair	5
Multicenter Pivotal Trial of the Minima Stent for Vascular Stenosis in Infants and Young Children	5
When Fixing Hinders, Why We Should Sometimes Fight the Urge to Fix	5
Transcatheter Interventions in Adults With Fontan Palliation	5
Stroke Prevention With Prophylactic Left Atrial Appendage Occlusion in Cardiac Surgery Patients Without Atrial Fibrillation: A Meta-Analysis of Randomized and Propensity-Score Studies	5
Response by Puymirat and Danchin to Letter Regarding Article, “Compared Outcomes of ST-Segment–Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coron	5
Unfolding Mystery of Aortic Transcatheter Valve Doppler Gradient and Clinical Outcomes	5
Microvascular Resistance Reserve Predicts Myocardial Ischemia and Response to Therapy in Patients With Angina and Nonobstructive Coronary Arteries	5
Amputation After Endovascular Therapy With and Without Intravascular Ultrasound Guidance: A Nationwide Propensity Score–Matched Study	5
How to Improve Radiation Protection in Interventional Cardiology Procedures	5
Pharmaco-Invasive Strategy With Half-Dose Tenecteplase in Patients With STEMI: Prespecified Pooled Analysis of Patients Aged ≥75 Years in STREAM-1 and 2	5
Characterization of Cerebral Embolic Capture Using the SENTINEL Device During Transcatheter Aortic Valve Implantation in Low to Intermediate-Risk Patients: The SENTINEL-LIR Study	5
Physician-Modified Endograft–Facilitated Transcatheter Pulmonary Valve Replacement in Large Right Ventricular Outflow Tract	5
Impact of Bypass Conduit and Early Technical Failure on Revascularization for Chronic Limb-Threatening Ischemia	5
Cardiac Reverse Remodeling and Changes in Heart Failure Indices After Transcatheter Tricuspid Valve Replacement in Adults With Congenital Heart Disease	5
Percutaneous Management of High-Risk Pulmonary Embolism	5
Five-Year Clinical Outcomes and Durability of a Self-Expanding Transcatheter Heart Valve With Intra-Annular Leaflets	5
Evaluation of Bioprosthetic Valve Dysfunction in the SMART Randomized Clinical Trial	4
Economic Considerations in Access to Transcatheter Aortic Valve Replacement	4
Comparison of Ultrathin- Versus Thin-Strut Stents in Patients With High Bleeding Risk PCI: Results From the COMPARE 60/80 HBR Trial: An Open-Label, Randomized, Controlled Trial	4
Three-Dimensional CT for Preprocedural Planning of PCI for Ostial Right Coronary Artery Lesions: A Randomized Controlled Pilot Trial	4
Prognostic Value of Measuring Fractional Flow Reserve After Percutaneous Coronary Intervention in Patients With Complex Coronary Artery Disease: Insights From the FAME 3 Trial	4
Prospective Observational Study on the Accuracy of Predictors of Permanent Pacemaker Secondary to High-Grade Atrioventricular Conduction Block After TAVI (CONDUCT-TAVI)	4
Chronic Total Occlusions With Multivessel Disease; Does Bypass Grafting Beat Percutaneous Coronary Intervention?	4
Correlation and Relative Prognostic Value of Fractional Flow Reserve and Pd/Pa of Nonculprit Lesions in ST-Segment–Elevation Myocardial Infarction	4
Clinical Outcomes of Deferred Lesions by IVUS Versus FFR-Guided Treatment Decision	4